$40.93
0.68% today
Nasdaq, Feb 05, 04:16 pm CET
ISIN
US04963C2098
Symbol
ATRC

AtriCure, Inc. Stock price

$40.65
+7.16 21.38% 1M
+19.22 89.69% 6M
+10.09 33.02% YTD
+7.57 22.88% 1Y
-23.81 36.94% 3Y
+1.15 2.91% 5Y
+21.62 113.61% 10Y
Nasdaq, Closing price Tue, Feb 04 2025
+0.95 2.39%
ISIN
US04963C2098
Symbol
ATRC
Sector

Key metrics

Market capitalization $1.98b
Enterprise Value $1.93b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 4.31
P/S ratio (TTM) P/S ratio 4.43
P/B ratio (TTM) P/B ratio 4.26
Revenue growth (TTM) Revenue growth 17.56%
Revenue (TTM) Revenue $447.57m
EBIT (operating result TTM) EBIT $-34.16m
Free Cash Flow (TTM) Free Cash Flow $-1.15m
Cash position $130.34m
EPS (TTM) EPS $-0.83
P/E forward negative
P/S forward 4.29
EV/Sales forward 4.17
Short interest 3.11%
Show more

Is AtriCure, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

AtriCure, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a AtriCure, Inc. forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a AtriCure, Inc. forecast:

Buy
100%

Financial data from AtriCure, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
448 448
18% 18%
100%
- Direct Costs 116 116
21% 21%
26%
332 332
16% 16%
74%
- Selling and Administrative Expenses 267 267
15% 15%
60%
- Research and Development Expense 81 81
20% 20%
18%
-16 -16
18% 18%
-4%
- Depreciation and Amortization 18 18
34% 34%
4%
EBIT (Operating Income) EBIT -34 -34
25% 25%
-8%
Net Profit -39 -39
57% 57%
-9%

In millions USD.

Don't miss a Thing! We will send you all news about AtriCure, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AtriCure, Inc. Stock News

Neutral
Business Wire
14 days ago
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its fourth quarter and full year 2024 financial results on Wednesday, February 12, 2025. AtriCure will host an audio webcast at 4:30 p...
Neutral
Business Wire
23 days ago
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced preliminary financial results for the fourth quarter and full year 2024 and provided 2025 financial guidance. Additionally, AtriCure announced that it will ...
Neutral
Business Wire
about one month ago
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming 43rd Annual J.P. Morgan Healthcare Conference. AtriCure's management is scheduled to present on Wedn...
More AtriCure, Inc. News

Company Profile

AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.

Head office United States
CEO Michael Carrel
Employees 1,200
Founded 1994
Website www.atricure.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today